Ligand Reports First Quarter 2022 Financial Results
Ligand to Report First Quarter Financial Results on May 4
Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
Ligand to Report Fourth Quarter Financial Results on February 17
